OpenAlex
PricingAboutJobs
Log inGet started
Work

Clarithromycin (Biaxin)-Lenalidomide-Low-Dose Dexamethasone (BiRd) Versus Lenalidomide-Low-Dose Dexamethasone (Rd) as Initial Therapy for Newly Diagnosed Multiple Myeloma.

HTML

Year: 2009
Type: article
Study design: Observational Study
Source: Blood
DOI: 10.1182/blood.v114.22.2868.2868
Authors: Francesca Gay, S. Vincent Rajkumar, David S Jayabalan, Shaji Kumar, Tomer Mark, Angela Dispenzieri, Roger Pearse, Morie A Gertz, John P Leonard, Martha Q Lacy, Selina Chen-Kiang, Vivek Roy, Morton Coleman, Suzanne R. Hayman, Francis Buadi, John A. Lust, Thomas E. Witzig, Rafael Fonseca, Robert A Kyle, Philip R. Greipp, A. Keith Stewart, Ruben Niesvizky
Institutions: Mayo Clinic, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Mayo Clinic in Arizona
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2563387146
FWCI: 0.594
Cites:
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms